Assessment of Serum Vaspin Levels among Type 2 Diabetes Mellitus Patients with or without Acute Coronary Syndrome

• Main Authors: Aswathy Jaya Sathyaseelan, Prashant Shankarrao Adole, Mukta Wyawahare, Rama Prakasha Saya
• Format: Article
• Language: English
• Published: JCDR Research and Publications Private Limited 2016-12-01
• Series: Journal of Clinical and Diagnostic Research
• Subjects: adipokines; coronary artery disease; diabetic patients
• Online Access: https://jcdr.net/articles/PDF/8952/22417_CE[Ra]_F(Sh)_PF1(AH_RK)_PFA(AK)_PF2(PAG).pdf

Introduction: Type 2 Diabetes Mellitus (DM) is on the verge of becoming a pandemic in India. Type 2 DM patient have two to four times increased risk of carotid artery disease. Adipokines have been regarded recently as direct link between diabetes and atherosclerosis. Visceral Adipose Tissue Derived Serine Protease Inhibitor (VASPIN); one of the most recently discovered adipokine, inhibits the proteases responsible for insulin resistance, carotid plaque development and rupture. In literature, few studies have addressed the role of vaspin in pathogenesis of Acute Coronary Syndrome (ACS) in patients with type 2 DM. Aim: To find association between serum vaspin with lipid profile, creatine kinase-total, creatine kinase-MB, troponin-I, age, height, weight, blood pressure, smoking, family history of ACS and to prove the hypothesis of low serum vaspin level as predictor of ACS in patients with type 2 DM. Materials and Methods: Forty-one type 2 DM patients (controls) and 41 type 2 DM patients with ACS (cases) were enrolled in the study. Anthropometric measurements were performed and fasting serum biochemical parameters and vaspin were measured. The results of cases and controls were compared by student t-test or Mann–Whitney test. All the parameters were correlated with serum vaspin by Pearson’s or Spearman’s correlation. Results: Fasting serum vaspin concentration was significantly (p< 0.0001) lower in the cases (0.43±0.22 pg/ml) than in the controls (0.83±0.29 pg/ml). Correlation analysis undertaken on all type 2 DM showed that serum vaspin concentration was negatively correlated with age, waist circumference, hip circumference, systolic and diastolic blood pressure, duration of diabetes, serum Creative Kinase-Total, CK-MB and urea (p< 0.05). Utilizing Receiver Operating Characteristic (ROC) curve, the serum vaspin level of less than 0.594pg/ml showed greatest risk of ACS among type 2 DM patients (p< 0.0001). Conclusion: Type 2 DM patients with low serum vaspin concentration were at risk of ACS independent of other cardiovascular risk factors.